Table 1 Baseline demographic, clinical and angiographic data of patients with and without complete ST-resolution
Variables | Complete ST-resolution N = 35 (72.9%) | Incomplete ST-resolution N = 13 (27.1%) | P value | |
|---|---|---|---|---|
Mean age (years ± SD) | 54.9 ± 12.01 | 57.15 ± 13.05 | 0.58 | |
Hypertension, n (%) | 7 (20%) | 2 (15.4%) | 0.71 | |
Diabetes Mellitus, n (%) | 4 (11.4%) | 2 (15.4%) | 0.65 | |
Hyperlipidemia, n (%) | 4 (11.4%) | 0 (0%) | 0.56 | |
Smoking, n (%) | 15 (42.9%) | 6 (46.2%) | 0.83 | |
Ischemic time | ≤6 h | 21 (60%) | 4 (30.8%) | 0.07 |
>6 h | 14 (40%) | 9 (69.2%) | ||
Medication use on admission Aspirin, n (%) | 3 (8.57%) | 2 (15.38%) | 0.6 | |
Beta-blockers, n (%) | 1 (2.86%) | 1 (7.7%) | 0.47 | |
ACE-inhibitors, n (%) | 4 (11.4%) | 1 (7.7%) | 0.7 | |
Statins, n (%) | 1 (2.86%) | 0 (0%) | 0.53 | |
Mean Syntax score ± SD | 20.48 ± 9.04 | 21.92 ± 9.92 | 0.63 | |
Mean Systolic blood pressure ± SD, mmHg | 132.20 ± 26.03 | 129.66 ± 24.59 | 0.77 | |
Mean Diastolic blood pressure ± SD, mmHg | 83.48 ± 16.22 | 78.16 ± 13.94 | 0.32 | |
LVEF, (%) ± SD | 41.61 ± 10.27 | 43.84 ± 4.63 | 0.45 | |
Anterior MI, n (%) | 19 (54.3%) | 7 (53.8%) | 0.97 | |
Pre-procedural TIMI flow, n (%) | 0.31 | |||
0–1 | 31 (88.6%) | 10 (76.9%) | ||
2–3 | 4 (11.4%) | 3 (23.1%) | ||